Uni-Bio Science Group (HKSE:00690) Total Equity: HK$413.2 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Uni-Bio Science Group Total Equity?

Uni-Bio Science Group HKSE:00690 Total Equity is HK$413.2 Mil as of Dec. 2025. The stock has 3 warning signs investors should review.

Uni-Bio Science Group's total equity for the quarter that ended in Dec. 2025 was HK$413.2 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Uni-Bio Science Group Total Equity Historical Data

* Premium members only.

The historical data trend for Uni-Bio Science Group's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Uni-Bio Science Group Total Equity Chart

Uni-Bio Science Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 174.31 194.75 257.17 325.65 413.25

Uni-Bio Science Group Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 257.17 312.65 325.65 382.85 413.25

Uni-Bio Science Group Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Uni-Bio Science Group's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=579.803-166.556
=413.2

Uni-Bio Science Group's Total Equity for the quarter that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=579.803-166.556
=413.2

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of HK$413.2 Mil mean?
Uni-Bio Science Group (HKSE:00690) has a Total Equity of HK$413.2 Mil as of Dec. 2025. The total amount of equity as record on a company's balance sheet. View historical data for Uni-Bio Science Group and its competitors.
Is Uni-Bio Science Group's Total Equity too high?
Uni-Bio Science Group's current Total Equity is HK$413.2 Mil.
How does Uni-Bio Science Group's Total Equity compare to VRTX and REGN?
Uni-Bio Science Group's Total Equity of HK$413.2 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Biotechnology company?
A good Total Equity depends on the Biotechnology industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Uni-Bio Science Group and its competitors. Uni-Bio Science Group's current Total Equity is HK$413.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Uni-Bio Science Group stock overvalued right now?
Based on GuruFocus' analysis, Uni-Bio Science Group (HKSE:00690) is currently considered Possible Value Trap. The stock's GF Value™ is HK$0.09, compared to a current price of HK$0.06 — trading 34.4% below its estimated fair value. The current Total Equity is HK$413.2 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Uni-Bio Science Group (HKSE:00690), the current Total Equity is HK$413.2 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Uni-Bio Science Group Business Description

Address No. 20 Science Park East Avenue, Unit 502, 5th Floor, Hong Kong Science Park, Shatin, New Territories, Hong Kong, HKG
Uni-Bio Science Group Ltd is an investment holding company. It operates in three segments: Chemical pharmaceutical products, Biological pharmaceutical products, and Pipeline products. Its geographical segments are Hong Kong and China, of which all of its revenue comes from China. The company products include GeneSoft, GeneTime, Pinup, Boshutai, Bokangtai, and others. All of the company revenue is generated from PRC.